No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr12:48397400-48399400 |
Flanking Bivalent TSS/Enh |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
2 |
chr12:48397600-48399400 |
Flanking Bivalent TSS/Enh |
ES-UCSF4 Cell Line |
embryonic stem cell
|
3 |
chr12:48397800-48399600 |
Bivalent/Poised TSS |
HUES48 Cell Line |
embryonic stem cell
|
4 |
chr12:48397800-48399800 |
Bivalent Enhancer |
Fetal Lung |
lung
|
5 |
chr12:48398000-48399400 |
Bivalent/Poised TSS |
iPS-18 Cell Line |
embryonic stem cell
|
6 |
chr12:48398200-48399400 |
Bivalent Enhancer |
Primary B cells from peripheral blood |
blood
|
7 |
chr12:48398600-48399400 |
Bivalent Enhancer |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
8 |
chr12:48398600-48399400 |
Flanking Active TSS |
H9 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
9 |
chr12:48398600-48399400 |
Flanking Active TSS |
H9 Derived Neuron Cultured Cells |
ES cell derived
|
10 |
chr12:48398600-48399400 |
Flanking Bivalent TSS/Enh |
HUES6 Cell Line |
embryonic stem cell
|
11 |
chr12:48398600-48399600 |
Flanking Bivalent TSS/Enh |
H1 Cell Line |
embryonic stem cell
|
12 |
chr12:48398600-48399600 |
Flanking Bivalent TSS/Enh |
iPS-20b Cell Line |
embryonic stem cell
|
13 |
chr12:48398600-48399600 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
14 |
chr12:48398800-48399400 |
Flanking Bivalent TSS/Enh |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
15 |
chr12:48398800-48399400 |
Flanking Bivalent TSS/Enh |
HUES64 Cell Line |
embryonic stem cell
|
16 |
chr12:48398800-48399400 |
Bivalent Enhancer |
Fetal Muscle Trunk |
muscle
|
17 |
chr12:48398800-48399400 |
Bivalent Enhancer |
Fetal Muscle Leg |
muscle
|
18 |
chr12:48398800-48399400 |
Bivalent Enhancer |
Fetal Stomach |
stomach
|
19 |
chr12:48398800-48399400 |
Strong transcription |
Right Atrium |
heart
|
20 |
chr12:48398800-48399400 |
Flanking Bivalent TSS/Enh |
HepG2 |
liver
|
21 |
chr12:48398800-48399600 |
Bivalent Enhancer |
Primary T cells fromperipheralblood |
blood
|
22 |
chr12:48399000-48399400 |
Flanking Bivalent TSS/Enh |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
23 |
chr12:48399000-48399400 |
Bivalent Enhancer |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
24 |
chr12:48399000-48399400 |
Bivalent Enhancer |
Fetal Adrenal Gland |
Adrenal Gland
|
25 |
chr12:48399000-48399400 |
Bivalent Enhancer |
Skeletal Muscle Female |
skeletal muscle
|
26 |
chr12:48399000-48399800 |
Flanking Bivalent TSS/Enh |
iPS-15b Cell Line |
embryonic stem cell
|
27 |
chr12:48399000-48400200 |
Bivalent Enhancer |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
28 |
chr12:48399200-48399400 |
Bivalent Enhancer |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
29 |
chr12:48399200-48399400 |
Bivalent Enhancer |
Primary hematopoietic stem cells |
blood
|
30 |
chr12:48399200-48399400 |
Bivalent Enhancer |
Primary T killer naive cells fromperipheralblood |
blood
|
31 |
chr12:48399200-48399600 |
Bivalent/Poised TSS |
H9 Cell Line |
embryonic stem cell
|
32 |
chr12:48399200-48399600 |
Bivalent Enhancer |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
33 |
chr12:48399200-48400000 |
Bivalent Enhancer |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
34 |
chr12:48399200-48400200 |
Enhancers |
H1 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|